Physicochemical Properties
| Molecular Formula | C40H72N12O8 |
| Molecular Weight | 849.08 |
| CAS # | 2240202-02-0 |
| Appearance | White to off-white solid powder |
| SMILES | C(N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N)CC(=O)N)(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CCC1CCCCC1 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Animal Protocol |
Animal/Disease Models:ddY mice[1]. Doses: 250, 100, 25 µg/mouse. Route of Administration: Applied to the nasal cavity. Experimental Results: Suppressed body weight gain of mice in a dose-dependent manner. |
| References |
[1]. A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorg Med Chem. 2020 May 15;28(10):115454. |
Solubility Data
| Solubility (In Vitro) | May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples |
| Solubility (In Vivo) | CPN-219 was dissolved in saline[1]. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.1777 mL | 5.8887 mL | 11.7775 mL | |
| 5 mM | 0.2355 mL | 1.1777 mL | 2.3555 mL | |
| 10 mM | 0.1178 mL | 0.5889 mL | 1.1777 mL |